Are side-chain oxidized oxysterols regulators also in vivo?
Oxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain ox...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520306143 |
id |
doaj-4dffd69127994acdbc7c047618e69805 |
---|---|
record_format |
Article |
spelling |
doaj-4dffd69127994acdbc7c047618e698052021-04-28T05:55:51ZengElsevierJournal of Lipid Research0022-22752009-01-0150S213S218Are side-chain oxidized oxysterols regulators also in vivo?Ingemar Bjo¨rkhem0To whom correspondence should be addressed; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, SwedenOxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain oxidized oxysterols may be mediators of many cholesterol-induced regulatory effects. When added to cultured cells in vitro, side-chain oxidized oxysterols limit intracellular cholesterol levels by at least three different mechanisms: 1) binding to Insig with subsequent block of the sterol regulatory element-binding proteins (SREBP)-mediated mechanism for regulation of sterol sensitive genes; 2) increasing degradation of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, eventually by a mechanism involving binding of Insig to the enzyme; 3) activation of LXR-mediated stimulation of cholesterol transporters and cholesterol metabolism. Addition of pure unesterified oxysterols to cell cultures is however highly unphysiological, and the in vivo relevance of such experiments is questionable. Transgenic mouse models with markedly reduced or increased concentration of some specific oxysterols do not present marked disturbances in cholesterol turnover and homeostasis. Oxysterol-binding proteins such as LXR have been conclusively shown to be of importance for cholesterol turnover in vivo, but their physiological ligands have not yet been defined with certainty. During the last few years, new experimental data has accumulated supporting the contention that side-chain oxysterols are involved in some LXR-mediated regulation in vivo, at least in some biological systems. The new findings will be critically reviewed here.http://www.sciencedirect.com/science/article/pii/S002222752030614327-Hydroxycholesterol24S-hydroxycholesterol25-hydroxycholesterol24,25-epoxycholesterol |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ingemar Bjo¨rkhem |
spellingShingle |
Ingemar Bjo¨rkhem Are side-chain oxidized oxysterols regulators also in vivo? Journal of Lipid Research 27-Hydroxycholesterol 24S-hydroxycholesterol 25-hydroxycholesterol 24,25-epoxycholesterol |
author_facet |
Ingemar Bjo¨rkhem |
author_sort |
Ingemar Bjo¨rkhem |
title |
Are side-chain oxidized oxysterols regulators also in vivo? |
title_short |
Are side-chain oxidized oxysterols regulators also in vivo? |
title_full |
Are side-chain oxidized oxysterols regulators also in vivo? |
title_fullStr |
Are side-chain oxidized oxysterols regulators also in vivo? |
title_full_unstemmed |
Are side-chain oxidized oxysterols regulators also in vivo? |
title_sort |
are side-chain oxidized oxysterols regulators also in vivo? |
publisher |
Elsevier |
series |
Journal of Lipid Research |
issn |
0022-2275 |
publishDate |
2009-01-01 |
description |
Oxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain oxidized oxysterols may be mediators of many cholesterol-induced regulatory effects. When added to cultured cells in vitro, side-chain oxidized oxysterols limit intracellular cholesterol levels by at least three different mechanisms: 1) binding to Insig with subsequent block of the sterol regulatory element-binding proteins (SREBP)-mediated mechanism for regulation of sterol sensitive genes; 2) increasing degradation of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, eventually by a mechanism involving binding of Insig to the enzyme; 3) activation of LXR-mediated stimulation of cholesterol transporters and cholesterol metabolism. Addition of pure unesterified oxysterols to cell cultures is however highly unphysiological, and the in vivo relevance of such experiments is questionable. Transgenic mouse models with markedly reduced or increased concentration of some specific oxysterols do not present marked disturbances in cholesterol turnover and homeostasis. Oxysterol-binding proteins such as LXR have been conclusively shown to be of importance for cholesterol turnover in vivo, but their physiological ligands have not yet been defined with certainty. During the last few years, new experimental data has accumulated supporting the contention that side-chain oxysterols are involved in some LXR-mediated regulation in vivo, at least in some biological systems. The new findings will be critically reviewed here. |
topic |
27-Hydroxycholesterol 24S-hydroxycholesterol 25-hydroxycholesterol 24,25-epoxycholesterol |
url |
http://www.sciencedirect.com/science/article/pii/S0022227520306143 |
work_keys_str_mv |
AT ingemarbjorkhem aresidechainoxidizedoxysterolsregulatorsalsoinvivo |
_version_ |
1721504949420949504 |